Found 287 clinical trials
COVID-19 and HPV Clinical Trial - W1600
Receive up to $750 to participate in the Covid-19 & HPV Vaccine Study. Must be 9-12 years old.As a participant you will receive both the HPV and Covid-19 Vaccine
- 6 views
- 29 Sep, 2022
- 2 locations
Study of HB-200 alone and with pembrolizumab for patients with Recurrent/ Metastatic HPV 16+ Head and Neck and other Cancers
and HB-202 in people. HPV is a group of more than 200 related viruses, each given a number. HPV 16 is one of the highest risk groups for HPV-related cancers. The
- 0 views
- 27 May, 2022
- 16 locations
RTOG 1016: Phase III Trial of Radiotherapy Plus Cetuximab Versus Chemoradiotherapy in HPV-Associated Oropharynx Cancer
RTOG 1016: Phase III Trial of Radiotherapy Plus Cetuximab Versus Chemoradiotherapy in HPV-Associated Oropharynx Cancer
- 766 views
- 08 Nov, 2020
- 1 location
Longitudinal Clinical Evaluation of the HPV Assay on the BD Viper LT System with Cervical Specimens
Longitudinal Clinical Evaluation of the HPV Assay on the BD Viper LT System with Cervical Specimens
- 434 views
- 08 Nov, 2020
- 1 location
Edtech-HPV: A Community Approach Using Education and Technology to Increase HPV Vaccination (Edtech-HPV)
increasing the rate of HPV vaccination completion among children of Mexican Americans. The investigator's have extended the duration that participants are followed in assessing their child's uptake of
- 429 views
- 31 Jan, 2022
- 3 locations
Provider Recommendation and HPV Vaccination (HPVV)
In the United State, there are millions of US teens who are not vaccinated against the human papillomavirus (HPV) putting them at risk of getting HPV-related cancers. Although there are clinical
- 31 views
- 30 May, 2022
- 1 location
Provider-Focused Intervention for Maximizing HPV Vaccine Uptake in Young Cancer Survivors
The focus of this research is on increasing the uptake of the human papillomavirus (HPV) vaccine in young cancer survivors, a vulnerable population at high risk for developing new cancers (such
- 0 views
- 26 May, 2022
- 6 locations
Multilevel Interventions to Enhance Provider Recommendations for HPV Vaccination
Each year the human papillomavirus (HPV) causes 30,000 cancers in the United States despite the availability of very effective and safe vaccines. Uptake of the HPV vaccine has been
- 156 views
- 04 Oct, 2022
- 1 location
Text and Talk: A Multi-level Intervention to Increase Provider HPV Vaccine Recommendation Effectiveness (Text&Talk)
This study will test the effectiveness of two interventions (parent-targeted text messages and a brief clinician-targeted training) at increasing HPV vaccination among 11- to 12-year-olds living
- 0 views
- 04 Oct, 2022
- 1 location
Randomized Phase II Study of Cisplatin Plus Radiotherapy Versus Durvalumab Plus Radiotherapy Followed by Adjuvant Durvalumab Versus Durvalumab Plus Radiotherapy Followed by Adjuvant Tremelimumab and Durvalumab in Intermediate Risk HPV-Positive Locoregionally Advanced Oropharyngeal Squamous Cell Cancer (LA-OSCC)
Sometimes, cancer patients receive an initial treatment, followed by additional treatment to lower the chance of cancer coming back. The standard or usual treatment for this type of disease is initially having radiation therapy at the same time as chemotherapy (with a drug called cisplatin), with no additional therapy afterwards
- 144 views
- 25 Oct, 2022
- 25 locations